Skip to content
10-Q

Quarterly Report

HOOKIPA PHARMA INC.

0001558370-24-015711

← back to feed
Filed
Nov 14, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2024 · Sep 30, 2024 12.54M sh
Shares Diluted Q3 2024 · Sep 30, 2024 12.54M sh
Shares Diluted restated Q3 2024 · Sep 30, 2023 11.04M sh
Shares Diluted restated Q3 2024 · Sep 30, 2023 8.86M sh
Capex Q3 2024 · Sep 30, 2024 $192K
Capex Q3 2024 · Sep 30, 2023 $3.74M
Operating Cash Flow Q3 2024 · Sep 30, 2024 −$56.04M
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$46.3M
Cash And Equivalents Q3 2024 · Sep 30, 2024 $59.75M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $117.1M
Stockholders Equity Q3 2024 · Sep 30, 2024 $71.8M
Stockholders Equity Q3 2024 · Jun 30, 2024 $86.06M
Stockholders Equity Q3 2024 · Mar 31, 2024 $104.52M
Stockholders Equity Q3 2024 · Dec 31, 2023 $89.86M
Stockholders Equity Q3 2024 · Sep 30, 2023 $95.05M
Stockholders Equity Q3 2024 · Jun 30, 2023 $112.33M
Stockholders Equity Q3 2024 · Mar 31, 2023 $83.48M
Stockholders Equity Q3 2024 · Dec 31, 2022 $102.52M
Current Liabilities Q3 2024 · Sep 30, 2024 $28.57M
Current Liabilities Q3 2024 · Dec 31, 2023 $41.99M
Total Liabilities Q3 2024 · Sep 30, 2024 $37.93M
Total Liabilities Q3 2024 · Dec 31, 2023 $71.48M
Current Assets Q3 2024 · Sep 30, 2024 $93.16M
Current Assets Q3 2024 · Dec 31, 2023 $147.12M
Total Assets Q3 2024 · Sep 30, 2024 $109.73M
Total Assets Q3 2024 · Dec 31, 2023 $161.34M
Eps Diluted Q3 2024 · Sep 30, 2024 −$1.10
Eps Diluted Q3 2024 · Sep 30, 2024 −$1.48
Eps Diluted restated Q3 2024 · Sep 30, 2023 −$1.73
Eps Diluted restated Q3 2024 · Sep 30, 2023 −$6.41
Eps Basic Q3 2024 · Sep 30, 2024 −$1.10
Eps Basic Q3 2024 · Sep 30, 2024 −$1.48
Eps Basic restated Q3 2024 · Sep 30, 2023 −$1.73
Eps Basic restated Q3 2024 · Sep 30, 2023 −$6.41
Sga Expense Q3 2024 · Sep 30, 2024 $6.73M
Sga Expense Q3 2024 · Sep 30, 2024 $14.73M
Sga Expense Q3 2024 · Sep 30, 2023 $4.91M
Sga Expense Q3 2024 · Sep 30, 2023 $14.26M
Rd Expense Q3 2024 · Sep 30, 2024 $15.57M
Rd Expense Q3 2024 · Sep 30, 2024 $55.48M
Rd Expense Q3 2024 · Sep 30, 2023 $24.63M
Rd Expense Q3 2024 · Sep 30, 2023 $65.26M
Net Income Q3 2024 · Sep 30, 2024 −$13.84M
Net Income Q3 2024 · Sep 30, 2024 −$18.55M
Net Income Q3 2024 · Jun 30, 2024 −$19.1M
Net Income Q3 2024 · Mar 31, 2024 $14.38M
Net Income Q3 2024 · Dec 31, 2023 −$81.6M
Net Income Q3 2024 · Sep 30, 2023 −$19.07M
Net Income Q3 2024 · Sep 30, 2023 −$56.76M
Net Income Q3 2024 · Jun 30, 2023 −$18.02M
Net Income Q3 2024 · Mar 31, 2023 −$19.68M
Operating Income Q3 2024 · Sep 30, 2024 −$18.64M
Operating Income Q3 2024 · Sep 30, 2024 −$30M
Operating Income Q3 2024 · Sep 30, 2023 −$22.67M
Operating Income Q3 2024 · Sep 30, 2023 −$66.8M
Revenue Q3 2024 · Sep 30, 2024 $4.7M
Revenue Q3 2024 · Sep 30, 2024 $42.59M
Revenue Q3 2024 · Sep 30, 2023 $6.87M
Revenue Q3 2024 · Sep 30, 2023 $12.72M